Warning: The NCBI web site requires JavaScript to function. more...

My NCBI Sign In

Result Filters

J Nat Prod. 2009 Sep;72(9):1637-42.

Antineoplastic agents. 579. Synthesis and cancer cell growth evaluation of E-stilstatin 3: a resveratrol structural modification.

Pettit GR, Melody N, Thornhill A, Knight JC, Groy TL, Herald CL.

Source

Cancer Research Institute and Department of Chemistry and Biochemistry, Arizona State University, Tempe, AZ 85287-1604, USA. bpettit@asu.edu

Abstract

As an extension of our earlier structure/activity investigation of resveratrol (1a) cancer cell growth inhibitory activity compared to the structurally related stilbene combretastatin series (e.g., 2a), an efficient synthesis of E-stilstatin 3 (3a) and its phosphate prodrug 3b was completed. The trans-stilbene 3a was obtained using a convergent synthesis employing a Wittig reaction with phosphonium bromide 9 as the key reaction step. Deprotection of the Z-silyl ether 13 gave E-stilstatin 3 (3a) as the exclusive product. The structure and stereochemistry of 3a was confirmed by X-ray crystal structure determination.

PMID:: 19719153; [PubMed - indexed for MEDLINE]
PMCID:: PMC2782413

Free PMC Article

Images from this publication.See all images (4) Free text

Scheme 1

Scheme 3

Scheme 2

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Other Literature Sources

Molecular Biology Databases

RESVERATROL - HSDB

Supplemental Content

Icon for American Chemical Society

Icon for PubMed Central

Save items

loading

Related citations in PubMed

Antineoplastic agents. 578. Synthesis of stilstatins 1 and 2 and their water-soluble prodrugs. [J Nat Prod. 2009]
Antineoplastic agents. 578. Synthesis of stilstatins 1 and 2 and their water-soluble prodrugs.
Pettit GR, Thornhill A, Melody N, Knight JC. J Nat Prod. 2009 Mar 27; 72(3):380-8.
Antineoplastic agents. 465. Structural modification of resveratrol: sodium resverastatin phosphate. [J Med Chem. 2002]
Antineoplastic agents. 465. Structural modification of resveratrol: sodium resverastatin phosphate.
Pettit GR, Grealish MP, Jung MK, Hamel E, Pettit RK, Chapuis JC, Schmidt JM. J Med Chem. 2002 Jun 6; 45(12):2534-42.
Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-41. [J Med Chem. 2005]
Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-41.
Pettit GR, Rhodes MR, Herald DL, Hamel E, Schmidt JM, Pettit RK. J Med Chem. 2005 Jun 16; 48(12):4087-99.
Review Naphthalene combretastatin analogues: synthesis, cytotoxicity and antitubulin activity. [J Enzyme Inhib Med Chem. 2004]
Review Naphthalene combretastatin analogues: synthesis, cytotoxicity and antitubulin activity.
Medarde M, Maya AB, Pérez-Melero C. J Enzyme Inhib Med Chem. 2004 Dec; 19(6):521-40.
Review Resveratrol and resveratrol analogues--structure-activity relationship. [Pharm Res. 2010]
Review Resveratrol and resveratrol analogues--structure-activity relationship.
Szekeres T, Fritzer-Szekeres M, Saiko P, Jäger W. Pharm Res. 2010 Jun; 27(6):1042-8. Epub 2010 Mar 16.

See reviews... See all...

Cited by 1 PubMed Central article

An efficient synthetic strategy for obtaining 4-methoxy carbon isotope labeled combretastatin A-4 phosphate and other Z-combretastatins. [J Nat Prod. 2010]
An efficient synthetic strategy for obtaining 4-methoxy carbon isotope labeled combretastatin A-4 phosphate and other Z-combretastatins.
Pettit GR, Minardi MD, Hogan F, Price PM. J Nat Prod. 2010 Mar 26; 73(3):399-403.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
BioAssay
PubChem BioAssay experiments on the biological activities of small molecules that cite the current articles. The depositors of BioAssay data provide these references.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Antineoplastic agents. 579. Synthesis and cancer cell growth evaluation of E-sti...
Antineoplastic agents. 579. Synthesis and cancer cell growth evaluation of E-stilstatin 3: a resveratrol structural modification.
J Nat Prod. 2009 Sep ;72(9):1637-42.

PubMed
Increased 7,8-dihydroneopterin and reduced methyl-group metabolism in HIV-1 infe...
Increased 7,8-dihydroneopterin and reduced methyl-group metabolism in HIV-1 infection.
Lancet. 1990 May 12 ;335(8698):1167.

PubMed
Need for risk adjustment in adapting episode grouping software to Medicare data.
Need for risk adjustment in adapting episode grouping software to Medicare data.
Health Care Financ Rev. 2009 Summer ;30(4):33-46.

PubMed
Prevention and drug treatment.
Prevention and drug treatment.
Future Child. 2009 Fall ;19(2):147-68.

PubMed
Body image and sexuality in women with pelvic organ prolapse.
Body image and sexuality in women with pelvic organ prolapse.
Urol Nurs. 2009 Jul-Aug ;29(4):239-46.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

You are here: NCBI > Literature > PubMed

Write to the Help Desk